Document Detail


Developments in the treatment of severe influenza: lessons from the pandemic of 2009 and new prospects for therapy.
MedLine Citation:
PMID:  25333476     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: Cases of severe influenza may occur during seasonal epidemics, following sporadic zoonotic influenza A transmission from animal reservoirs or on a massive scale with the unpredictable emergence of a new pandemic influenza strain. Clinical experience identifies unmet medical need for additional therapies for influenza, in particular to treat severely unwell adults and children. During and following the pandemic of 2009, a wealth of data from hospitalized cases of influenza from many different countries accumulated and are now starting to emerge. Observational clinical data provide information about the efficacy of existing antiviral drugs in severely ill patients. The development pipeline for new therapies contains several promising agents which are focussed on a range of viral targets, and opens the possibility of combination antiviral therapy for the first time, which may be especially useful in clinically challenging cases. Advances in immunological methods and recombinant protein engineering support the potential for use of immunomodulating therapies as adjuncts in treatment of severe influenza.
RECENT FINDINGS: The main themes are the importance of treating severe influenza early, considering multiple therapy options and the relevance of observational clinical data to treatment of severely ill and risk groups.
SUMMARY: Clinicians, who may have only seen the media headlines following discussion of reviews which deal with randomized controlled trials of neuraminidase inhibitor drug use in mild uncomplicated influenza in the community, may be hesitant to prescribe these drugs. Observational data arising from treatment of severely ill individuals support use of these drugs early in illness and show improvement in outcomes associated with drug use.
Authors:
Maria Zambon
Related Documents :
22627006 - Drug discovery in pharmaceutical industry: productivity challenges and trends.
11224186 - Factors influencing the reinforcing and subjective effects of d-amphetamine in humans.
16541246 - The effect of stress on absorption of acetaminophen.
6791226 - Drug preference and mood in humans: preference for d-amphetamine and subject characteri...
10668576 - Pharmacological treatment of erectile dysfunction.
3337796 - Comparative in vivo and in vitro assessment of the percutaneous absorption of local ana...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-20
Journal Detail:
Title:  Current opinion in infectious diseases     Volume:  -     ISSN:  1473-6527     ISO Abbreviation:  Curr. Opin. Infect. Dis.     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-10-21     Completed Date:  -     Revised Date:  2014-10-22    
Medline Journal Info:
Nlm Unique ID:  8809878     Medline TA:  Curr Opin Infect Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomide Chemotherapy: Differentiatio...
Next Document:  State-Specific Reactions of Cu(+)((1)S,(3)D,(1)D) with the Super Greenhouse Gas SF5CF3.